Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Double-blind, Randomized, Placebo-controlled Trial of Minocycline in Clinically Isolated Syndromes (CIS) and Early Single Relapse Multiple Sclerosis (MS)

NCT00666887 is registered in ClinicalTrials.gov with Dr. Luanne Metz as lead sponsor.

NCT NCT00666887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00666887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Double-blind, Randomized, Placebo-controlled Trial of Minocycline in Clinically Isolated Syndromes (CIS) and Early Single Relapse Multiple Sclerosis (MS)
Lead sponsor
Dr. Luanne Metz
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2009
Completion date
July 31, 2015
Enrollment
142 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

clinically isolated syndromes, early single relapse of multiple sclerosis